Implantable cardiac device to promote intrinsic rhythm to alleviate orthostatic hypotension

• US 7,171,270 B1
• Filed: 12/29/2003
• Issued: 01/30/2007
• Est. Priority Date: 12/29/2003
• Status: Active Grant

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Benser, Michael, Park, Euljoon, Lyons, Ruth
• Primary Examiner(s): Manuel; George
• Assistant Examiner(s): FAULCON JR, LENWOOD
• Application Number:
  US10/748,486
• Time in Patent Office: 1,128 Days
• Field of Search: 607/9, 607/17
• US Class Current: 607/17
• CPC Class Codes: A61N 1/36514 controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by two or more physical parameters A61N1/36585
• CPC Class Codes: A61N 1/36535 controlled by body position or posture
• CPC Class Codes: A61N 1/36542 controlled by body motion, e.g. acceleration
• CPC Class Codes: A61N 1/36564 controlled by blood pressure

Abstract

An implantable cardiac device is programmed to promote intrinsic rhythm of a patient'"'"'s heart to alleviate orthostatic hypotension. In one implementation, the cardiac device is set in a reduced rate mode while the patient is in a less upright position, such as when resting in a supine position. If the patient is in intrinsic rhythm when transitioning to a more upright position, the cardiac device disables administration of any increased pacing rate for a programmed duration. In this manner, the patient will experience a more natural variation in heart rate during transition from the less upright posture to the more upright posture (e.g., from supine to sitting or standing). On the other hand, if the patient is being paced during the transition, the cardiac device administers an increased base rate or triggers an orthostatic response algorithm.

Claims

1. An implantable cardiac device comprising:

circuitry to sense whether a patient is in intrinsic rhythm when transitioning from a less upright posture to a more upright posture; and

a processor to promote vasoconstrictive response of the patient'"'"'s heart by;

(i) in an event that the circuitry senses the patient is not in intrinsic rhythm, applying increased pacing to counter effects of orthostatic hypotension caused by the transition from the less upright posture to the more upright posture; and

(ii) in an event that the circuitry senses the patient is in intrinsic rhythm, disabling increased pacing for a programmed duration, wherein the programmed duration is approximately 5–

120 seconds.

2. An implantable cardiac device as recited in claim 1, wherein the circuitry comprises at least one of an activity sensor, an accelerometer, and a respiration sensor to sense the condition indicative of non-reset.

3. An implantable cardiac device as recited in claim 1, wherein the increased pacing is applied according to an orthostatic response algorithm.

4. An implantable cardiac device as recited in claim 1, wherein the processor applies increased pacing after the programmed duration expires.

5. An implantable cardiac device comprising:

detection means for detecting whether a patient is in intrinsic rhythm when transitioning from a first posture to a second posture, where the second posture is more upright than the first posture; and

responsive to the transition in posture, compensation means for temporarily disabling, for a programmed duration, application of increased pacing to counter effects of orthostatic hypotension if the patient is in intrinsic rhythm and subsequently applying, after expiration of the programmed duration, a pacing therapy;

wherein the programmed duration is approximately 5–

120 seconds.

6. An implantable cardiac device as recited in claim 5, wherein the compensation means applies a pacing therapy that includes increased pacing.

7. An implantable cardiac device as recited in claim 5, wherein the compensation means applies a pacing therapy that includes decreased pacing.

8. An implantable cardiac device as recited in claim 5, wherein the compensation means applies increased pacing without delay if the patient is not in intrinsic rhythm.

9. An implantable cardiac device having a memory and a processor, the cardiac device being programmed to perform tasks comprising countering orthostatic hypotension by disabling, for a programmed duration, application of increased pacing to a patient who is in intrinsic rhythm when transitioning from a first posture to a second posture that is more upright than the first posture, the programmed duration being approximately 5–

120 seconds.

10. An implantable and programmable cardiac device as recited in claim 9, further programmed to perform tasks comprising subsequently applying the increased pacing after the programmed duration lapses.

11. A method implemented by an implantable cardiac device, comprising:

sensing when a patient transitions from a less upright posture to a more upright posture; and

disabling increased pacing responsive to the transition if the patient'"'"'s heart is in intrinsic rhythm to promote a vasoconstrictive response, wherein said disabling is for a programmed duration, and wherein the programmed duration is approximately 5–

120 seconds.

12. A method as recited in claim 11, wherein the sensing comprises monitoring at least one of a respiration-related parameter, an activity variance, or a position-related parameter.

13. A method as recited in claim 11, wherein the sensing comprises determining when the patient, who is at rest, exhibits indicia of non-rest.

14. A method as recited in claim 11, further comprising administering increased pacing after expiration of the programmed duration.

15. A method as recited in claim 11, further comprising administering decreased pacing after expiration of the programmed duration.

16. A method comprising:

when a patient is at rest, determining whether the patient'"'"'s heart is in intrinsic rhythm;

detecting a condition indicative of non-rest;

if the patient'"'"'s heart is not in intrinsic rhythm, administering increased pacing upon detection of the condition to counter effects of orthostatic hypotension; and

if the patient'"'"'s heart is in intrinsic rhythm, disabling administration of the increased pacing for a programmed duration to promote vasoconstrictive response of the patient'"'"'s heart, wherein the programmed duration is approximately 5–

120 seconds.

17. A method as recited in claim 16, wherein the detecting comprises monitoring the patient'"'"'s position.

18. A method as recited in claim 16, wherein the detecting comprises monitoring patient activity.

19. A method as recited in claim 16, further comprising subsequently increasing pacing after the programmed duration expires.